The USPTO has become involved in the CRISPR-Cas9 patent dispute.
A court of appeals will not reconsider the validity of Sequenom's '540 patent, saying it is bound by previous cases regarding patenting laws of nature.
The report, which takes a look at patent issues as it relates to confirmatory genetic tests, acknowledged that federal legislation has dramatically changed the landscape in recent years.
The Australian High Court rules that isolated genetic material cannot be patented.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
A decision is expected soon in Australia's gene patenting court case.
Patent law experts said the ruling provides further clarity over what is and is not patentable within the broader molecular diagnostics field.
The decision invalidates 13 claims of a patent that is at the center of litigation filed by Illumina alleging infringement by Ariosa Diagnostics.
By a GenomeWeb staff reporter
Myriad's stock took a hit on Tuesday after a federal District Court declared the firm's BRCA gene patents were invalid.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.
National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.